[Federal Register Volume 87, Number 223 (Monday, November 21, 2022)]
[Notices]
[Page 70832]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25276]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Deputy Director for Infectious
Diseases (BSC, DDID)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the Board of Scientific Counselors, Deputy
Director for Infectious Diseases (BSC, DDID). This virtual meeting is
open to the public via Zoom, limited only by the number of web
conference lines available (500 lines). Pre-registration is required by
accessing the link below in the addresses section.
DATES: The meeting will be held on December 7, 2022, from 9:00 a.m. to
5:15 p.m., EST, and December 8, 2022, from 8:30 a.m. to 1:00 p.m., EST.
ADDRESSES: Zoom virtual meeting. Pre-registration is required by
accessing the link at https://cdc.zoomgov.com/webinar/register/WN_PbAc34lET9uD2RN8lopzig. Instructions to access the meeting will be
provided following registration.
FOR FURTHER INFORMATION CONTACT: Laura Hughes-Baker, Ph.D., Designated
Federal Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta,
Georgia 30329-4027; Telephone: (404) 639-1402; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The BSC, DDID provides advice and guidance to the
Secretary, Department of Health and Human Services; the Director, CDC;
the CDC Deputy Director for Infectious Diseases; and the Directors of
the National Center for Emerging and Zoonotic Infectious Diseases, the
National Center for HIV, Viral Hepatitis, STD, and TB Prevention, and
the National Center for Immunization and Respiratory Diseases, CDC,
concerning strategies, goals, and priorities for the programs and
research within the national centers and monitors the overall strategic
direction and focus of DDID and the national centers.
Matters to be Considered: The agenda will include updates and
discussions on recent outbreaks and affected populations, as well as
brief reports from two of the Board's workgroups: the Food Safety
Modernization Act Surveillance Working Group and the Acute Flaccid
Myelitis Task Force. Agenda items are subject to change as priorities
dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-25276 Filed 11-18-22; 8:45 am]
BILLING CODE 4163-18-P